Projected Income Statement: Stryker Corporation

Forecast Balance Sheet: Stryker Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 9,453 9,929 7,879 7,695 11,848 9,125 5,893 2,525
Change - 5.04% -20.65% -2.34% 53.97% -22.98% -35.42% -57.15%
Announcement Date 27/01/22 31/01/23 30/01/24 28/01/25 29/01/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Stryker Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 525 588 575 755 761 859.2 911.4 955.1
Change - 12% -2.21% 31.3% 0.79% 12.9% 6.07% 4.8%
Free Cash Flow (FCF) 1 2,738 2,036 3,105 3,487 4,283 4,017 4,979 5,701
Change - -25.64% 52.5% 12.3% 22.83% -6.21% 23.94% 14.52%
Announcement Date 27/01/22 31/01/23 30/01/24 28/01/25 29/01/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Stryker Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 27.78% 25.77% 26.09% 27.18% 28.13% 28.63% 28.94% 29.57%
EBIT Margin (%) 25.61% 23.76% 24.17% 25.29% 26.29% 26.71% 27.17% 27.81%
EBT Margin (%) 13.33% 14.54% 17.92% 15.45% 17.97% 21.56% 23.18% 23.84%
Net margin (%) 11.66% 12.78% 15.44% 13.25% 12.92% 18.14% 19.4% 20.04%
FCF margin (%) 16% 11.04% 15.15% 15.43% 17.05% 14.74% 16.81% 17.86%
FCF / Net Income (%) 137.31% 86.34% 98.1% 116.51% 131.95% 81.28% 86.65% 89.12%

Profitability

        
ROA 10.08% 9.99% 10.59% 11.34% 11.6% 10.83% 11.7% 11.96%
ROE 24.85% 22.68% 23.1% 23.96% 24.47% 23.32% 22.66% 21.33%

Financial Health

        
Leverage (Debt/EBITDA) 1.99x 2.09x 1.47x 1.25x 1.68x 1.17x 0.69x 0.27x
Debt / Free cash flow 3.45x 4.88x 2.54x 2.21x 2.77x 2.27x 1.18x 0.44x

Capital Intensity

        
CAPEX / Current Assets (%) 3.07% 3.19% 2.81% 3.34% 3.03% 3.15% 3.08% 2.99%
CAPEX / EBITDA (%) 11.05% 12.37% 10.75% 12.29% 10.77% 11.01% 10.63% 10.12%
CAPEX / FCF (%) 19.17% 28.88% 18.52% 21.65% 17.77% 21.39% 18.31% 16.75%

Items per share

        
Cash flow per share 1 8.535 6.866 9.591 11 13.05 14.72 18.56 21
Change - -19.56% 39.7% 14.7% 18.63% 12.78% 26.07% 13.19%
Dividend per Share 1 2.585 2.835 3.05 3.24 3.4 3.598 3.828 4.112
Change - 9.67% 7.58% 6.23% 4.94% 5.83% 6.39% 7.42%
Book Value Per Share 1 39.41 43.93 48.98 54.16 58.66 68.6 79.5 92.44
Change - 11.48% 11.49% 10.57% 8.31% 16.94% 15.89% 16.28%
EPS 1 5.21 6.17 8.25 7.76 8.4 12.86 14.73 16.62
Change - 18.43% 33.71% -5.94% 8.25% 53.15% 14.49% 12.87%
Nbr of stocks (in thousands) 3,77,240 3,78,430 3,79,938 3,81,216 3,82,424 3,83,573 3,83,573 3,83,573
Announcement Date 27/01/22 31/01/23 30/01/24 28/01/25 29/01/26 - - -
1USD
Estimates
2026 *2027 *
P/E 21.3x 18.6x
PBR 4x 3.45x
EV / Sales 4.2x 3.75x
Yield 1.31% 1.4%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
274.19USD
Average target price
372.68USD
Spread / Average Target
+35.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SYK Stock
  4. Financials Stryker Corporation
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!